Carregando...
Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patients
For monitoring minimal residual disease (MRD) in chronic myeloid leukemia (CML) the most recommended method is quantitative RT-PCR (RT-qPCR) for measuring BCR-ABL1 transcripts. Several studies reported that a DNA-based assay enhances the sensitivity of detection of the BCR-ABL1 genomic rearrangement...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Principais autores: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834283/ https://ncbi.nlm.nih.gov/pubmed/29541390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23971 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|